Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease

被引:0
|
作者
Marusia Lilova
Bernard S. Kaplan
Kevin E. C. Meyers
机构
[1] The Children's Hospital of Philadelphia,Division of Nephrology and Department of Pediatrics
[2] The Children's Hospital of Philadelphia,Division of Nephrology
[3] University of Pennsylvania,undefined
来源
Pediatric Nephrology | 2003年 / 18卷
关键词
Autosomal recessive polycystic kidney disease; Growth hormone; Growth; Chronic renal failure;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with autosomal recessive polycystic kidney disease (ARPKD) may have growth retardation that is disproportionate to the degree of renal dysfunction. We treated growth-retarded ARPKD patients with recombinant growth hormone (rhGH) and document the response to therapy and effect of rhGH on the rate of progression of renal failure. The diagnosis of ARPKD and congenital hepatic fibrosis was made on the basis of clinical findings and by abdominal ultrasound examinations. Seventeen patients (6 girls/11 boys) aged 0.3–18.3 years were studied. Diagnosis was made prenatally in 6, after birth in 3, and in 8 between 0.33 and 10 years. Follow-up was 2 months to 14.3 years (median 6.9 years). Growth, growth velocity, weight, and bone age were measured before and after treatment with rhGH. Insulin-like growth factor-1 and IGF binding protein 3 were measured prior to rhGH therapy. Five children (1 girl/4 boys) with height Z-scores ≤1.2 (5/17) aged 4.5–11.9 years received rhGH therapy. Duration of rhGH therapy was 0.3–5.4 years. All responded to rhGH (Z-score before –2.8 vs. –1.26 after treatment, P=0.03). An increase in height Z-score was noted 0.5–1.5 years after starting rhGH therapy. There were no side effects from rhGH therapy. The initial Z-score in the untreated group was –0.35 and the final score was –0.64. Initial glomerular filtration rate (GFR) in the treated group was 77 versus 104 ml/min per 1.73 m2 in the non−treated group. GFR in 3 of 6 growth-retarded patients (<5th percentile) was 38, 65, and 30 ml/min per 1.73 m2. GFR in 2 of 11 non-growth-retarded patients was 30 and 26 ml/min per 1.73 m2. The change from initial GFR and final GFR in treated patients was 77 versus 76 ml/min per 1.73 m2, and non−treated patients 104 versus 89 ml/min per 1.73 m2 (P>0.05). Growth failure in ARPKD may be attributable to factors other than chronic renal insufficiency alone. Use of rhGH therapy in ARPKD is safe, effective, and has the potential to improve the physical and psychological well-being of these children.
引用
收藏
页码:57 / 61
页数:4
相关论文
共 50 条
  • [31] Liver Involvement in Autosomal Recessive Polycystic Kidney Disease
    Bramlage, Mary Alexandra
    Sang, Jessica L.
    Lewis, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1981 - S1981
  • [32] Genetic characterization of autosomal recessive polycystic kidney disease
    Casey J.
    Nature Clinical Practice Nephrology, 2006, 2 (6): : 295 - 295
  • [33] Prenatal diagnosis in autosomal recessive polycystic kidney disease
    Gagnadoux, MF
    Attié, T
    Amiel, J
    Gigarel, N
    Bonnefont, JP
    Munnich, A
    Gubler, MC
    Antignac, C
    ARCHIVES DE PEDIATRIE, 2000, 7 (09): : 942 - 947
  • [34] Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease
    Cordido, Adrian
    Vizoso-Gonzalez, Marta
    Garcia-Gonzalez, Miguel A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [35] Transcriptional Complexity in Autosomal Recessive Polycystic Kidney Disease
    Frank, Valeska
    Zerres, Klaus
    Bergmann, Carsten
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (10): : 1729 - 1736
  • [36] RENAL MACROPHAGES IN AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE
    Mrug, Michal
    Zhou, Juling
    Guay-Woodford, Lisa M.
    Smythies, Lesley E.
    NEPHROLOGY, 2013, 18 (11) : 746 - 746
  • [37] Situs inversus with autosomal recessive polycystic kidney disease
    Jayakrishnan, M. P.
    Devarajan, E.
    INDIAN PEDIATRICS, 2008, 45 (08) : 701 - 702
  • [38] Autosomal Recessive Polycystic Kidney Disease: Case Report
    Stevanovic, Radmila
    Glumac, Sofija
    Trifunovic, Jovanka
    Medjo, Biljana
    Nastasovic, Tijana
    Markovic-Lipkovski, Jasmina
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2009, 137 (5-6) : 288 - 291
  • [39] Autosomal recessive polycystic kidney disease diagnosed in fetus
    Thomas, Joseph
    Manjunath, A. P.
    Rai, Lavanya
    Kudva, Ranjini
    INDIAN JOURNAL OF UROLOGY, 2007, 23 (03) : 328 - 329
  • [40] Role of CFTR in autosomal recessive polycystic kidney disease
    Nakanishi, K
    Sweeney, WE
    Dell, KM
    Cotton, CU
    Avner, ED
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (04): : 719 - 725